NUVL Nuvalent, Inc.

HealthcareBiotechnology
$105.28
2.81%
44
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
35
Short-Term
52
P/E-18.40
8
P/B7.05
43
P/S0.00
70
EV/EBITDA-20.91
5
Revenue Growth0.0%
28
EPS Growth-48.9%
40
FCF Growth-48.7%
39
12-Month Return57.8%
90
3-Month Return1.6%
63
1-Month Return0.7%
54
RSI (14)44.57
50
50/200 MABullish
75
ROE-42.8%
43
ROA-33.8%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-4.0%
0
Beta1.15
75
60-Day Volatility30.8%
42

Generated 5/9/2026, 9:14:04 AM · How is this calculated?

Get an email when the QScore signal flips. No daily noise.
QScore Analysis
NUVL QScore 44/100 — Hold | QScoring